|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest-bearing deposits in banks | ||||||||||||||||||||
| Investment securities available for sale, at fair value (amortized cost $433,631 and $414,884, respectively) | ||||||||||||||||||||
| Investment securities held to maturity (fair values of $531 and $1,066, respectively) | ||||||||||||||||||||
| Mortgage loans held for sale | ||||||||||||||||||||
| Loans, net of unearned income | ||||||||||||||||||||
| Allowance for loan losses | ||||||||||||||||||||
| Total loans, net of unearned income and allowance for loan losses | ||||||||||||||||||||
| Office properties and equipment, net | ||||||||||||||||||||
| Cash surrender value of bank-owned life insurance | ||||||||||||||||||||
| Goodwill and core deposit intangibles | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated debt, net of issuance cost | ||||||||||||||||||||
| Short-term Federal Home Loan Bank advances | ||||||||||||||||||||
| Long-term Federal Home Loan Bank advances | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value - 10,000,000 shares authorized; none issued | ||||||||||||||||||||
| Common stock, $0.01 par value - 40,000,000 shares authorized; 7,868,139 and 7,831,342 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Unallocated common stock held by: | ||||||||||||||||||||
| Employee Stock Ownership Plan | ||||||||||||||||||||
| Recognition and Retention Plan (RRP) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...
